Avelqor Labs Selank 10 mg laboratory research material

Selank 10 mg – Laboratory Research Material

CHF 54.90
Zu Produktinformationen springen
Avelqor Labs Selank 10 mg laboratory research material

Selank 10 mg – Laboratory Research Material

CHF 54.90

✓ In stock / Auf Lager · Swiss dispatch / Versand Schweiz · Tracked shipping / Tracking

AVELQOR10 · 10% off / Rabatt · Batch / COA documentation where available · Zahlungsarten im Checkout

Bank Transfer Available at checkout

Manual bank transfer can be selected during the normal Shopify checkout. Orders are processed after payment has been received and matched to the order.

Related research materials

PRODUKTDETAILS

Forschung, Spezifikationen & Dokumentation

Klar gegliederte Produktinformationen für Labor- und Analyseabläufe.

Order & Documentation at a Glance

Availability In stock
Dispatch From Switzerland with tracked shipping
Launch offer AVELQOR10 · 10% off · no minimum
Documentation Batch / COA resources where available
Payment Available methods are shown in the live checkout

Review batch documentation · Shipping & payment

Selank 10 mg – Laboratory Research Material

Selank 10 mg is listed as a lyophilized peptide research material for cognitive, neurotransmitter, cytokine and analytical laboratory research.

Research-Only Notice

For laboratory research use only. Not for human or animal consumption, administration, medical, cosmetic or household use.

Product Specifications

Material Selank
Form Lyophilized laboratory research material
Declared content 10 mg
Availability In stock
Intended use Laboratory and analytical research only

Reference Identity & Technical Data

Synonyms Selank · Selanc · TP-7
CAS Registry Number 129954-34-3
Reference molecular formula C33H57N11O9
Reference molecular weight 751.87 g/mol
Reference sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro
Sequence shortening TKPRPGP
Research class Tuftsin-derived peptide · GABA-related neuropeptide research
Purity / identity Lot-specific; refer only to documentation attributable to the applicable Avelqor batch

Reference identifiers describe the named research compound in external technical catalogues and literature. They do not by themselves verify the identity, purity, counterion/salt state or assay of an Avelqor vial; batch-specific Avelqor documentation controls.

Research Overview

The supplied HYBIO Peptide Product Reference Guide (2026) describes Selank as a synthetic decapeptide analogue of Tuftsin developed in Russia and places it in cognitive, neurotransmitter and immunomodulatory research.

Mechanistic Research Context

The guide discusses research involving GABA/5-HT neurotransmitter balance and cytokine modulation, including IL-6-related pathways. These mechanistic directions do not establish an anxiolytic, antidepressant or other therapeutic effect for this Avelqor research material.

Laboratory Research Areas

  • Neuropeptide and neurotransmitter-signalling research
  • GABA/5-HT pathway models
  • Cytokine and immunomodulatory research
  • Cognitive and stress-response research models
  • Comparative peptide characterization

Evidence & Limitations

The guide notes that the evidence base comes mainly from Soviet/Russian research, with limited independent Western replication. It lists 5 mg and 10 mg lyophilized formats as secondary research forms. This limitation should remain clear whenever research findings are summarized.

Documentation & Traceability

Batch or lot references and supporting analytical documentation are published only where available and attributable to the relevant material. Documentation should be linked only where attributable to the corresponding material and batch.

COA & Batch Documentation · Quality & Testing

Laboratory Handling & Storage

Keep sealed and protected from direct light under the conditions stated on the final product label. Follow laboratory SOPs and document batch identifiers, receipt dates and storage conditions. No preparation, dosing or administration instructions are provided.

Important Use Restriction

Research use only. Not for human or veterinary use, consumption or administration. No clinical, psychiatric, cognitive-enhancement or consumer-use claim is made.

Reference basis: supplied HYBIO Peptide Product Reference Guide (2026); source statements have not been independently validated by Avelqor Labs.